Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptide elongation factor 2 (eEF2) is an essential GTP-binding protein involved in the process of protein synthesis in eukaryotic and archaeal cells. It catalyzes the GTP-dependent translocation step during mRNA translation, promoting the movement of ribosomes along mRNA after peptide bond formation. Its activity is tightly regulated by phosphorylation, and it is targeted by bacterial toxins like diphtheria toxin and exotoxin A, which inhibit its function and lead to cell death.
ADP-ribosylation of diphthamide residue, leading to inhibition of protein synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptide Elongation Factor 2 (eEF2).